XBiotech Inc.
XBIT
$2.92
-$0.06-2.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.64M | 5.62M | 4.71M | 4.57M | 4.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.54M | 45.17M | 42.47M | 42.31M | 42.93M |
| Operating Income | -36.54M | -45.17M | -42.47M | -42.31M | -42.93M |
| Income Before Tax | -28.14M | -39.44M | -38.56M | -32.75M | -34.80M |
| Income Tax Expenses | 25.00K | -28.00K | -32.00K | -90.00K | 209.00K |
| Earnings from Continuing Operations | -28.16 | -39.41 | -38.53 | -32.66 | -35.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.16M | -39.41M | -38.53M | -32.66M | -35.01M |
| EBIT | -36.54M | -45.17M | -42.47M | -42.31M | -42.93M |
| EBITDA | -34.78M | -43.41M | -40.73M | -40.57M | -41.19M |
| EPS Basic | -0.92 | -1.29 | -1.27 | -1.07 | -1.15 |
| Normalized Basic EPS | -0.58 | -0.81 | -0.79 | -0.67 | -0.71 |
| EPS Diluted | -0.92 | -1.29 | -1.27 | -1.08 | -1.15 |
| Normalized Diluted EPS | -0.58 | -0.81 | -0.79 | -0.67 | -0.71 |
| Average Basic Shares Outstanding | 121.91M | 121.88M | 121.84M | 121.82M | 121.78M |
| Average Diluted Shares Outstanding | 121.91M | 121.88M | 121.84M | 121.82M | 121.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |